Skip to main content
Equibles

MORGAN STANLEY

Position in ANIX — Anixa Biosciences Inc

CIK 895421 NEW YORK, NY
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,199
-$22,811 QoQ
Shares Held
6,143
-60.4% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 62 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ANIX ranks #405 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in ANIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,199 6,143
2026-03-31 $40,010 15,508
2025-12-31 $146,202 46,860
2025-09-30 $38,507 11,669
2025-06-30 $70,629 21,403
2025-03-31 $95,308 33,325
2024-12-31 $73,662 31,751
2024-09-30 $100,487 31,901
2024-06-30 $76,246 34,501
2024-03-31 $115,864 37,136
2023-12-31 $141,514 36,473
2023-09-30 $120,534 36,861
2023-06-30 $130,755 40,861
2023-03-31 $184,102 42,815
2022-12-31 $222,193 52,281
2022-09-30 $257,261 52,289
2022-06-30 $166,047 54,264
2022-03-31 $183,896 67,116
2021-12-31 $161,988 54,542
2021-09-30 $206,125 43,213
2021-06-30 $219,728 56,631
2021-03-31 $40,804 8,719
2020-12-31 $69,246 22,556
2020-09-30 $35,196 14,484
2020-06-30 $77,831 25,435
2020-03-31 $22,915 14,412